YTHDF1 and neoplasm: Therefore, YTHDF1 deletion may enhance antitumor immunity by facilitating interactions with DCs, rather than promoting their differentiation and proliferation, supporting a potential role of YTHDF2 as a tumor immunosuppressive factor.